Patent · US Active

CD73 inhibitors

US11377469B2 · kind B2 · utility

2Cited by

3References

19Claims

0Family size

Assignee

ORIC PHARMACEUTICALS, INC. · US

Inventors

Xiaohui Du · Foster City, US
John Eksterowicz · Burlingame, US
Valeria R. FANTIN · Burlingame, US
Erica L. Jackson · Burlingame, US
Daqing Sun · Foster City, US
Qiuping YE · Foster City, US
Jared MOORE · San Rafael, US
Tatiana Zavorotinskaya · Moraga, US

Key dates

Filing date	Nov 2, 2018
Grant date	Jul 5, 2022
Priority date	—
Expiry date	Nov 2, 2038

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61K45/06
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Described herein are CD73 inhibitors and pharmaceutical compositions comprising said compounds. The subject compounds and compositions are useful for the treatment of cancer, infections, and neurodegenerative diseases.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.